| |||||
| Clinical Trial-Related Regulatory Environment in Belgium-USD
| |||||
|
** This is a downloadable product ** This Knowledge Brief provides information on the recent regulatory changes and clarifications that occurred in Belgium concerning the requirements related to the CTA and the declaration of Investigational Medicinal Products (IMPs). It also provides an overview of expectations to meet in order to run a clinical trial in Belgium, with references to the appropriate required documents. |
Member Price: $ 0.00 / € 0.00 Non-Member Price: $ 5.00 / € 3.00 Item #KB0014US | ||||
 back to product listadd to your shopping cart
|
|||||
Please note: ISPE does not pay customs or duties on international shipping.
View Our Shipping and Return Policy